Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
Coll freshman Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 4.5 Description of the Company's Securities
- 10.8 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Eli Casdin
- 10.9 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Keith Meister
- 10.10 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Brian Emes
- 10.11 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Shaun Rodriguez
- 10.12 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Sean George
- 10.13 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Munib Islam
- 10.14 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Emily Leproust
- 10.15 Indemnity Agreement, Dated September 1, 2020, by and Between the Company and Nat Turner
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
WGS similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of CM Life Sciences, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian Emes, Chief Financial Officer and Secretary of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 30, 2021
By: | /s/ Brian Emes | |
Brian Emes | ||
Chief Financial Officer and Secretary | ||
(Principal Financial and Accounting Officer) |